14K prolactin derived 14‐mer antiangiogenic peptide targets bradykinin‐/nitric oxide‐cGMP‐dependent angiogenesis
Over the past few decades, VEGF‐targeted antiangiogenic therapy for cancers has gained increasing attention. Nevertheless, there are still several limitations such as the potential resistance mechanisms arising in cancer cells against these therapies and their potential adverse effects. These limita...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | FEBS Open Bio |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/2211-5463.13895 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|